A Study to Evaluate INCB186748 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
Clinical trial NCT06818812 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06818812
- Sponsor
- Incyte Corporation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-27
- Primary completion
- 2027-03-27
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.